Healthcare - Biotechnology - NASDAQ - US
$ 1.83
-3.17 %
$ 91.1 M
Market Cap
-0.59
P/E
BALANCE SHEET
344 M
ASSETS
78.9 M
LIABILITIES
266 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
HilleVax, Inc.
| Current Assets | 311 M |
| Cash & Short-Term Investments | 303 M |
| Receivables | 0 |
| Other Current Assets | 7.2 M |
| Non-Current Assets | 33.8 M |
| Long-Term Investments | 0 |
| PP&E | 32.1 M |
| Other Non-Current Assets | 1.66 M |
| Current Liabilities | 29.3 M |
| Accounts Payable | 7.46 M |
| Short-Term Debt | 6.24 M |
| Other Current Liabilities | 15.6 M |
| Non-Current Liabilities | 49.6 M |
| Long-Term Debt | 48.1 M |
| Other Non-Current Liabilities | 1.57 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 216.7 | 279.4 | 124.6 | 0.5 | 0.4 |
| Short Term Investments | 86.8 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.2 | 11.2 | 0.1 | 48 K | 48 K |
| Total Current Assets | 310.7 | 290.6 | 124.7 | 0.5 | 0.5 |
| PP&E | 32.1 | 24.9 | 0.2 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.6 | 0 | 0 | 0 |
| Other Long Term Assets | 1.7 | 22 K | 2.2 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 344.4 | 317.2 | 127.2 | 0.5 | 0.5 |
| LIABILITIES | |||||
| Accounts Payable | 7.5 | 4.7 | 1.0 | 0.1 | 0.2 |
| Short Term Debt | 6.2 | 74 K | 158.3 | 3.0 | 0.9 |
| Other Current Liabilities | 15.6 | 8.2 | 68.4 | 0.1 | 14 K |
| Total Current Liabilities | 29.3 | 13.0 | 227.8 | 3.3 | 1.1 |
| Long Term Debt | 48.1 | 36.4 | 0.2 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 1.6 | 0.6 | 1 K | 0 | 0 |
| Total Liabilities | 78.9 | 50.0 | 227.9 | 3.3 | 1.1 |
| EQUITY | |||||
| Common Stock | 5 K | 4 K | 1 K | 0 | 0 |
| Retained Earnings | (388.6) | (265.0) | (105.2) | (2.8) | (0.7) |
| Other Accumulative Comprehensive Income/Loss | (0.9) | (0.3) | 0 | 0 | 0 |
| Total Equity | 265.5 | 267.2 | (100.8) | (2.8) | (0.7) |
| Total Liabilities and Equity | 344.4 | 317.2 | 127.2 | 0.5 | 0.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 40.6 | 37.7 | 30.2 | 30.2 | 30.2 |